Showing 1 - 18 results of 18 for search 'David A. Brafman', query time: 0.04s Refine Results
  1. 1
    The Emergence of Model Systems to Investigate the Link Between Traumatic Brain Injury and Alzheimer’s Disease

    The Emergence of Model Systems to Investigate the Link Between Traumatic Brain Injury and Alzheimer’s Disease by Gayathri Srinivasan, David A. Brafman

    Published 2022-02-01
    Get full text
    Article
  2. 2
    The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression

    The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression by William W. Kostes, David A. Brafman

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering

    Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering by Josh Cutts, Mehdi Nikkhah, David A. Brafman

    Published 2015-06-01
    Get full text
    Article
  4. 4
    Generation of 3X FLAG-tagged human embryonic stem cell (hESC) line to study WNT-induced β-catenin DNA interactions (HVRDe009-A-2)

    Generation of 3X FLAG-tagged human embryonic stem cell (hESC) line to study WNT-induced β-catenin DNA interactions (HVRDe009-A-2) by Joshua Cutts, Warner Kostes, David A. Brafman

    Published 2021-12-01
    Get full text
    Article
  5. 5
    Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering

    Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering by Josh Cutts, Mehdi Nikkhah, David A. Brafman

    Published 2015-01-01
    Get full text
    Article
  6. 6
    Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk

    Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk by Sreedevi Raman, Nicholas Brookhouser, David A. Brafman

    Published 2020-05-01
    Get full text
    Article
  7. 7
    May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells

    May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells by Nicholas Brookhouser, Sreedevi Raman, Christopher Potts, David. A. Brafman

    Published 2017-02-01
    Get full text
    Article
  8. 8
    Endogenous WNT Signaling Regulates hPSC-Derived Neural Progenitor Cell Heterogeneity and Specifies Their Regional Identity

    Endogenous WNT Signaling Regulates hPSC-Derived Neural Progenitor Cell Heterogeneity and Specifies Their Regional Identity by Noel Moya, Josh Cutts, Terry Gaasterland, Karl Willert, David A. Brafman

    Published 2014-12-01
    Get full text
    Article
  9. 9
    A chemically defined substrate for the expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells

    A chemically defined substrate for the expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells by Yihuan Tsai, Josh Cutts, Azuma Kimura, Divya Varun, David A. Brafman

    Published 2015-07-01
    Get full text
    Article
  10. 10
    Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant—Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A)

    Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant—Alzheimer's disease (ASUi005-A) a... by Nicholas Brookhouser, Ping Zhang, Richard Caselli, Jean J. Kim, David A. Brafman

    Published 2018-10-01
    Get full text
    Article
  11. 11
    Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant

    Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous... by Nicholas Brookhouser, Ping Zhang, Richard Caselli, Jean J. Kim, David A. Brafman

    Published 2017-12-01
    Get full text
    Article
  12. 12
    Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant

    Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous... by Nicholas Brookhouser, Ping Zhang, Richard Caselli, Jean J. Kim, David A. Brafman

    Published 2017-10-01
    Get full text
    Article
  13. 13
    A microcarrier-based protocol for scalable generation and purification of human induced pluripotent stem cell-derived neurons and astrocytes

    A microcarrier-based protocol for scalable generation and purification of human induced pluripotent stem cell-derived neurons and astrocytes by Jacob Knittel, Gayathri Srinivasan, Carlye Frisch, Nicholas Brookhouser, Sreedevi Raman, Albert Essuman, David A. Brafman

    Published 2022-09-01
    Get full text
    Article
  14. 14
    A Cas9-mediated adenosine transient reporter enables enrichment of ABE-targeted cells

    A Cas9-mediated adenosine transient reporter enables enrichment of ABE-targeted cells by Nicholas Brookhouser, Toan Nguyen, Stefan J. Tekel, Kylie Standage-Beier, Xiao Wang, David A. Brafman

    Published 2020-12-01
    Get full text
    Article
  15. 15
    Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States

    Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States by Emma K. Frow, David A. Brafman, Anna Muldoon, Logan Krum, Paige Williams, Bryson Becker, John P. Nelson, Ashley Pritchett

    Published 2019-08-01
    Get full text
    Article
  16. 16
    PINE-TREE enables highly efficient genetic modification of human cell lines

    PINE-TREE enables highly efficient genetic modification of human cell lines by Carlye Frisch, William W. Kostes, Brooke Galyon, Brycelyn Whitman, Stefan J. Tekel, Kylie Standage-Beier, Gayathri Srinivasan, Xiao Wang, David A. Brafman

    Published 2023-09-01
    Get full text
    Article
  17. 17
    Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research

    Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research by Suet Theng Beh, Carlye Frisch, David A. Brafman, Jared Churko, Jessica E. Walker, Geidy E. Serrano, Lucia I. Sue, Eric M. Reiman, Thomas G. Beach, Lih-Fen Lue

    Published 2020-10-01
    Get full text
    Article
  18. 18
    Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

    Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids by Jing Zhao, Yuan Fu, Yu Yamazaki, Yingxue Ren, Mary D. Davis, Chia-Chen Liu, Wenyan Lu, Xue Wang, Kai Chen, Yesesri Cherukuri, Lin Jia, Yuka A. Martens, Lucy Job, Francis Shue, Thanh Thanh Nguyen, Steven G. Younkin, Neill R. Graff-Radford, Zbigniew K. Wszolek, David A. Brafman, Yan W. Asmann, Nilüfer Ertekin-Taner, Takahisa Kanekiyo, Guojun Bu

    Published 2021-05-01
    Get full text
    Article

Search Tools: